Thalassemia is a hereditary blood disorder caused when the body does not make enough of a protein called haemoglobin which enables red blood cells to carry oxygen.
Thalassemia is a debilitating health condition which lessons a patients average life expectancy of fewer than 20 years. Around 300 million people around the world are affected by thalassemia & 100’s of thousands are left untreated in third world countries.
At our centre in Haripur hundreds of children are receiving regular blood transfusions, iron chelation therapy, and comprehensive medical monitoring to ensure they receive the best possible outcome. Hundreds of lives are being saved.
In November 2024, SMT expanded its operations to the Azad Kashmir District of Mirpur.
This decision followed significant demand from parents and donors who have connections to Azad Kashmir, particularly Mirpur.
SMT is actively in contact with many more families from other districts of Azad Kashmir who wish to register their thalassemia children. With the increasing number of patients, the average cost of care which includes all relevant transfusions and medications is in the region of £800 per patient for 12 months.
